Amgen Fails To Block Cipla’s Generic Cinacalcet In US, And It May Change How Patent Settlements Are Drafted

 
• By Sue Sutter
road trip, USA - Image
For now, Cipla has an open road to market its generic formulation of Amgen's Sensipar in the US. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics